Successful Kidney Transplant from Donors with Sickle Cell Disease: A Case Series of Six Transplants

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Prathap Kumar Simhadri , Felicitas Koller , Praise Matemavi , Mark Truman Earl , Deepak Chandramohan , Pradeep K. Vaitla
{"title":"Successful Kidney Transplant from Donors with Sickle Cell Disease: A Case Series of Six Transplants","authors":"Prathap Kumar Simhadri ,&nbsp;Felicitas Koller ,&nbsp;Praise Matemavi ,&nbsp;Mark Truman Earl ,&nbsp;Deepak Chandramohan ,&nbsp;Pradeep K. Vaitla","doi":"10.1016/j.xkme.2024.100875","DOIUrl":null,"url":null,"abstract":"<div><p>People with sickle cell disease experience a high incidence of chronic kidney disease and end-stage kidney disease, secondary to tubular and glomerular effects of vaso-occlusion-induced hypoxia. Because of concerns of suboptimal kidney function, sickle cell donors are usually not considered for kidney donation, even if the rest of the parameters are acceptable for organ donation. A significant gap exists between the number of organ donors and the number of candidates waiting for a kidney transplant in the United States. To bridge the gap, we need to consider using nontraditional donors. We report kidney transplant outcomes in 6 recipients from 4 sickle cell kidney donors. Intracranial hemorrhage and sepsis were the causes of the death in donors, and no donor was in sickle cell crisis at the time of donation. None of the recipients experienced delayed graft function, and all recipients achieved excellent allograft function. The earliest allograft failure was at 27 months in a recipient who developed early acute rejection, while the longest follow-up was 10 years with adequate kidney function. In conclusion, given the shortage of kidneys for transplantation and demonstrated good outcomes, we propose that kidneys from sickle cell donors can be safely used.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000864/pdfft?md5=0bf383d3423f5d044974a37bff6b7765&pid=1-s2.0-S2590059524000864-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

People with sickle cell disease experience a high incidence of chronic kidney disease and end-stage kidney disease, secondary to tubular and glomerular effects of vaso-occlusion-induced hypoxia. Because of concerns of suboptimal kidney function, sickle cell donors are usually not considered for kidney donation, even if the rest of the parameters are acceptable for organ donation. A significant gap exists between the number of organ donors and the number of candidates waiting for a kidney transplant in the United States. To bridge the gap, we need to consider using nontraditional donors. We report kidney transplant outcomes in 6 recipients from 4 sickle cell kidney donors. Intracranial hemorrhage and sepsis were the causes of the death in donors, and no donor was in sickle cell crisis at the time of donation. None of the recipients experienced delayed graft function, and all recipients achieved excellent allograft function. The earliest allograft failure was at 27 months in a recipient who developed early acute rejection, while the longest follow-up was 10 years with adequate kidney function. In conclusion, given the shortage of kidneys for transplantation and demonstrated good outcomes, we propose that kidneys from sickle cell donors can be safely used.

镰状细胞病捐献者的成功肾移植:六例移植病例系列
镰状细胞病患者由于血管闭塞引起的缺氧对肾小管和肾小球的影响,慢性肾病和终末期肾病的发病率很高。由于担心肾功能不达标,镰状细胞捐献者通常不被考虑捐献肾脏,即使其他参数可以接受器官捐献。在美国,器官捐献者的数量与等待肾移植的患者数量之间存在着巨大的差距。为了弥补这一差距,我们需要考虑使用非传统捐献者。我们报告了来自 4 名镰状细胞肾脏捐献者的 6 名受者的肾移植结果。颅内出血和败血症是导致捐献者死亡的原因,捐献者在捐献时均未出现镰状细胞危象。没有一名受者出现移植功能延迟,所有受者的同种异体移植功能都很好。最早出现同种异体移植失败的受者在 27 个月时出现了早期急性排斥反应,而最长的随访时间为 10 年,肾功能正常。总之,鉴于用于移植的肾脏短缺,且已证明疗效良好,我们建议可以安全地使用镰状细胞捐献者的肾脏。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信